<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-147934</identifier>
<setSpec>0300-2896</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Variability in Asthma Inflammatory Phenotype in Induced Sputum. Frequency and Causes</dc:title>
<dc:description xml:lang="en">Introduction: Recent studies have found variability in asthma inflammatory phenotypes determined by the inflammatory cells in induced sputum (IS). The aim of this study was to determine the frequency and factors affecting inflammatory phenotype variability in IS. Methods: Retrospective observational study that included 61 asthmatic patients who underwent at least two IS tests over a period of 5 years. They were classified according to their baseline inflammatory phenotype and subsequently grouped according to phenotype variability (persistent eosinophilic, persistent non-eosinophilic and intermittent eosinophilic). Demographic, clinical and functional data and factors potentially influencing IS variability were collected in all cases. Results: Of the 61 patients, 31 (50.8%) had a change with respect to baseline inflammatory phenotype. Of these, 16 (51.6%) were eosinophilic, 5 (16.1%) neutrophilic, 1 (3.2%) mixed and 9 (29.1%) paucigranulocytic. According to phenotype variability, 18 patients (29.5%) were classified as persistent eosinophilic, 17 (27.9%) non-persistent eosinophilic, and 26 (42.6%) intermittent eosinophilic. Smoking and recent asthma exacerbation were significantly associated with increased risk of variability of the IS inflammatory phenotype (OR=6.44; p=.013; 95% CI=1.49-27.80 and OR=5.84; p=.022; 95% CI=1.29-26.37, respectively). Conclusion: Half of asthma patients, predominantly those with eosinophilic phenotype, present a change in IS inflammatory phenotype. This variability is associated with smoking and recent asthma exacerbation. Data suggest these factors can modify the classification of IS inflammatory phenotype in clinical practice (AU)</dc:description>
<dc:creator>Suárez-Cuartín, Guillermo</dc:creator>
<dc:creator>Torrejón, Montserrat</dc:creator>
<dc:creator>Torrego, Alfons</dc:creator>
<dc:creator>Belda, Alicia</dc:creator>
<dc:creator>Plaza, Vicente</dc:creator>
<dc:creator>Ramos-Barbón, David</dc:creator>
<dc:creator>Crespo, Astrid</dc:creator>
<dc:creator>Mateus, Eder</dc:creator>
<dc:creator>Giner, Jordi</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Estudios recientes han constatado variabilidad del fenotipo inflamatorio del asma en el recuento de las células inflamatorias del esputo inducido (EI). El objetivo del presente estudio fue determinar la frecuencia y los factores que condicionan la variabilidad del fenotipo inflamatorio del EI. Métodos: Estudio observacional retrospectivo que incluyó 61 pacientes asmáticos a los que se les practicó un mínimo de dos EI en un período de 5 años. Los pacientes fueron clasificados según su fenotipo inflamatorio y posteriormente agrupados según la variabilidad del fenotipo (eosinofílicos persistentes, no eosinofílicos persistentes y eosinofílicos intermitentes). De todos los casos incluidos se recogieron datos demográficos y clínico-funcionales, así mismo se valoró los factores que pudiesen influir en la variabilidad del EI. Resultados: De los 61 pacientes, 31 (50,8%) presentaron un cambio del fenotipo inflamatorio inicial. De estos, 16 (51,6%) eran eosinofílicos, 5 (16,1%) neutrofílicos; 1 (3,2%) mixto y 9 (29,1%) paucigranulocíticos. Según la variabilidad, 18 pacientes (29,5%) se clasificaron como eosinofílicos persistentes, 17 (27,9%) no eosinofílicos persistentes y 26 (42,6%) eosinofílicos intermitentes. El tabaquismo y una exacerbación asmática reciente se asociaron significativamente con mayor riesgo de variabilidad del fenotipo inflamatorio del EI (OR=6,44; p=0,013; IC95%=1,49-27,80 y OR=5,84; p=0,022; IC95%=1,29-26,37, respectivamente). Conclusión: La mitad de los pacientes asmáticos modifican el fenotipo inflamatorio del EI, predominando los de fenotipo eosinofílico. Esta variabilidad se asocia al tabaquismo y a una exacerbación asmática reciente. Los datos sugieren que estos factores podrían influir en la determinación del fenotipo inflamatorio del EI en la práctica clínica habitual (AU)</dc:description>
<dc:source>Arch Bronconeumol;52(2): 76-81, feb. 2016. tab, graf</dc:source>
<dc:identifier>ibc-147934</dc:identifier>
<dc:title xml:lang="es">Variabilidad del fenotipo inflamatorio del asma en el esputo inducido. Frecuencia y causas</dc:title>
<dc:subject>^d2021</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d10833</dc:subject>
<dc:subject>^d4884^s22063</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4884^s22053</dc:subject>
<dc:subject>^d13530^s22039</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d13530^s22045</dc:subject>
<dc:subject>^d4884^s22010</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d13530^s22074</dc:subject>
<dc:subject>^d13568^s22010</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d13568^s22063</dc:subject>
<dc:subject>^d9692^s22053</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d1257^s22016</dc:subject>
<dc:subject>^d13568^s22046</dc:subject>
<dc:subject>^d1257^s22038</dc:subject>
<dc:type>article</dc:type>
<dc:date>201602</dc:date>
</metadata>
</record>
</ibecs-document>
